Trials / Conditions / Microsatellite Instability-high (MSI-H)
Microsatellite Instability-high (MSI-H)
6 registered clinical trials studyying Microsatellite Instability-high (MSI-H) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors NCT05909995 | Incyte Corporation | Phase 1 |
| Unknown | Cadonilimab as Neoadjuvant Therapy in Resectable Stage II-III MSI-H/dMMR Colorectal Cancer NCT05913570 | LiuYing | Phase 2 |
| Recruiting | Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer NCT05426005 | Sun Yat-sen University | Phase 1 / Phase 2 |
| Unknown | Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer NCT05371197 | Third Affiliated Hospital, Sun Yat-Sen University | Phase 2 |
| Recruiting | Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer NCT03926338 | Sun Yat-sen University | Phase 2 |
| Active Not Recruiting | Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) NCT03767348 | Replimune, Inc. | Phase 2 |